Historically, MS has been regarded as an adaptive immune response through the activation of autoreactive myelin specific T-cells, for example activation of autoreactive CD4+ T cells and their differentiation into T-helper 1 (Th1) cells is of particular importance in MS (Fletcher et al., 2010; Rostami and Ciric, 2013). Here, CD4 is linked to myeloid sarcoma.